Related Experiment Video
Updated: Jun 3, 2026
10:03
A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
[Recent advances in type 2 diabetes mellitus].
A Barthel1, H Rietzsch, S R Bornstein
1Medizinische Klinik und Poliklinik III, Universitätsklinikum Carl-Gustav-Carus der technischen Universität Dresden, Bochum. Andreas.Barthel@endokrinologikum.com
Deutsche Medizinische Wochenschrift (1946)
|March 31, 2011
Summary
Diagnosing type 2 diabetes relies on the oral glucose tolerance test, with risk scores and genetic data offering future prevention and treatment insights. Personalized therapeutic strategies and pharmacovigilance are crucial for managing this condition effectively.
Area of Science:
- Endocrinology
- Diabetes Mellitus Research
- Genetics
Background:
- The oral glucose tolerance test (OGTT) is the gold standard for diagnosing type 2 diabetes.
- HbA1c testing has limited diagnostic sensitivity for type 2 diabetes.
- Risk scores and questionnaires aid in assessing individual type 2 diabetes risk.
Purpose of the Study:
- To review current diagnostic standards for type 2 diabetes.
- To explore the role of risk stratification and genetic data in type 2 diabetes prevention and treatment.
- To emphasize the importance of personalized therapeutic strategies and pharmacovigilance.
Main Methods:
- Literature review of diagnostic methods for type 2 diabetes.
- Analysis of the utility of risk scores and genetic studies in diabetes management.
- Discussion of evolving therapeutic approaches and drug safety monitoring.
Main Results:
- OGTT remains the primary diagnostic tool, with HbA1c as a secondary measure.
- Risk assessment tools and genetic insights are valuable for predicting and preventing type 2 diabetes.
- Individualized treatment plans and robust pharmacovigilance are essential.
Conclusions:
- Personalized medicine, incorporating genetic data and risk profiles, will enhance type 2 diabetes prevention and treatment.
- Pharmacovigilance is critical for ensuring the safety and efficacy of an expanding range of type 2 diabetes therapies.
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...